Tesla’s vehicle deliveries in Q2 were slightly lower than Q1
On Sunday, electric vehicle manufacturer Tesla Motors shared figures related to the vehicles delivered by the company in the second quarter of 2016.
According to the figures released by Tesla, vehicles deliveries by the company in the April-June 2016 quarter were slightly lower than the vehicle deliveries reported by the company in the January-March 2016 quarter.
In all, Tesla delivered a total number of 14,370 vehicles in the second quarter this year; with 9,745 of the vehicles delivered by the company being Model S sedans, and 4,625 of the vehicles being Model X SUVs. The second-quarter vehicle deliveries fell short of the estimates, which projected that the company would deliver between 15,000 and 17,000 vehicles during the quarter.
In comparison to the second-quarter vehicle deliveries, the total number of vehicles delivered by Tesla in the first quarter this year was 14,820 vehicles. Tesla had, at that time, confirmed its full-year guidance of 80,000 to 90,000 vehicles.
Meanwhile, despite the lower than expected vehicle deliveries reported by Tesla for the second quarter, the company has asserted that it is hopeful of manufacturing and delivering 50,000 vehicles in the second half of 2016.
American aviation major Boeing has signaled its intent to unveil a modified version of its 737 MAX 10 aircraft at the opening of the Paris Airshow on Monday this week.
The odd dual-screen device called the YotaPhone 3 has been officially announced in the East Asian country of China for 2017 release.
After successfully launching its first X-ray space telescope, China is now preparing to launch four more space probes before 2021 as part of the ongoing efforts to develop space science.
The European Union (EU) is reportedly preparing to impose a record-high fine on tech giant Google (Alphabet) within the next few weeks, according to a WSJ report.
The U.S. Food & Drug Administration (FDA) has finally approved a new epinephrine injector for anaphylaxis, increasing competition for the controversially expensive injector EpiPen.
CenturyLink stock suffered major setback after Bloomberg published a report citing a former CenturyLink employee claiming that she was fired after she reported about fraud billing practices in the company.